231 related articles for article (PubMed ID: 28230714)
1. Assessment of skeletal tumour burden on 18F-NaF PET/CT using a new quantitative method.
Lapa P; Marques M; Costa G; Iagaru A; Pedroso de Lima J
Nucl Med Commun; 2017 Apr; 38(4):325-332. PubMed ID: 28230714
[TBL] [Abstract][Full Text] [Related]
2. Determination of Skeletal Tumor Burden on 18F-Fluoride PET/CT.
Rohren EM; Etchebehere EC; Araujo JC; Hobbs BP; Swanston NM; Everding M; Moody T; Macapinlac HA
J Nucl Med; 2015 Oct; 56(10):1507-12. PubMed ID: 26135112
[TBL] [Abstract][Full Text] [Related]
3. Comparison of [
Uprimny C; Svirydenka A; Fritz J; Kroiss AS; Nilica B; Decristoforo C; Haubner R; von Guggenberg E; Buxbaum S; Horninger W; Virgolini IJ
Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1873-1883. PubMed ID: 29766246
[TBL] [Abstract][Full Text] [Related]
4. Incremental Value of Cocktail 18F-FDG and 18F-NaF PET/CT Over 18F-FDG PET/CT Alone for Characterization of Skeletal Metastases in Breast Cancer.
Roop MJ; Singh B; Singh H; Watts A; Kohli PS; Mittal BR; Singh G
Clin Nucl Med; 2017 May; 42(5):335-340. PubMed ID: 28263210
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of bone-seeking novel radiotracer
Passah A; Tripathi M; Ballal S; Yadav MP; Kumar R; Roesch F; Meckel M; Sarathi Chakraborty P; Bal C
Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):41-49. PubMed ID: 27455986
[TBL] [Abstract][Full Text] [Related]
6. Repeatability of Quantitative 18F-NaF PET: A Multicenter Study.
Lin C; Bradshaw T; Perk T; Harmon S; Eickhoff J; Jallow N; Choyke PL; Dahut WL; Larson S; Humm JL; Perlman S; Apolo AB; Morris MJ; Liu G; Jeraj R
J Nucl Med; 2016 Dec; 57(12):1872-1879. PubMed ID: 27445292
[TBL] [Abstract][Full Text] [Related]
7. Uptake of Radium-223 Dichloride and Early [
Letellier A; Johnson AC; Kit NH; Savigny JF; Batalla A; Parienti JJ; Aide N
Mol Imaging Biol; 2018 Jun; 20(3):482-491. PubMed ID: 29027074
[TBL] [Abstract][Full Text] [Related]
8.
Wondergem M; van der Zant FM; Knol RJJ; Burgers AMG; Bos SD; de Jong IJ; Pruim J
World J Urol; 2018 Jan; 36(1):27-34. PubMed ID: 29043431
[TBL] [Abstract][Full Text] [Related]
9. The value of quantitative analysis in
Lapa P; Marques M; Costa G; Lima JP
Rev Esp Med Nucl Imagen Mol; 2017; 36(2):78-84. PubMed ID: 27793635
[TBL] [Abstract][Full Text] [Related]
10. [Superiority of 18F-FNa PET/CT for Detecting Bone Metastases in Comparison with Other Diagnostic Imaging Modalities].
Lapa P; Saraiva T; Silva R; Marques M; Costa G; Lima JP
Acta Med Port; 2017 Jan; 30(1):53-60. PubMed ID: 28501038
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Assessment of Early [
Harmon SA; Perk T; Lin C; Eickhoff J; Choyke PL; Dahut WL; Apolo AB; Humm JL; Larson SM; Morris MJ; Liu G; Jeraj R
J Clin Oncol; 2017 Aug; 35(24):2829-2837. PubMed ID: 28654366
[TBL] [Abstract][Full Text] [Related]
12. Prospective comparative study of
Fonager RF; Zacho HD; Langkilde NC; Fledelius J; Ejlersen JA; Hendel HW; Haarmark C; Moe M; Mortensen JC; Jochumsen MR; Petersen LJ
Acta Oncol; 2018 Aug; 57(8):1063-1069. PubMed ID: 29447047
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of extraskeletal computed tomography findings on 18F-NaF PET/CT performed for osseous metastatic disease evaluation.
Guo HH; Moradi F; Iagaru A
Nucl Med Commun; 2016 Sep; 37(9):975-82. PubMed ID: 27111100
[TBL] [Abstract][Full Text] [Related]
14. Prospective comparison of whole-body bone SPECT and sodium 18F-fluoride PET in the detection of bone metastases from breast cancer.
Abikhzer G; Srour S; Fried G; Drumea K; Kozlener E; Frenkel A; Israel O; Fogelman I; Kagna O
Nucl Med Commun; 2016 Nov; 37(11):1160-8. PubMed ID: 27536906
[TBL] [Abstract][Full Text] [Related]
15. Deep learning for segmentation of 49 selected bones in CT scans: First step in automated PET/CT-based 3D quantification of skeletal metastases.
Lindgren Belal S; Sadik M; Kaboteh R; Enqvist O; Ulén J; Poulsen MH; Simonsen J; Høilund-Carlsen PF; Edenbrandt L; Trägårdh E
Eur J Radiol; 2019 Apr; 113():89-95. PubMed ID: 30927965
[TBL] [Abstract][Full Text] [Related]
16.
Papadakis GZ; Manikis GC; Karantanas AH; Florenzano P; Bagci U; Marias K; Collins MT; Boyce AM
J Bone Miner Res; 2019 Sep; 34(9):1619-1631. PubMed ID: 31116487
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Challenge of Staging Metastatic Bone Disease in the Morbidly Obese Patients: A Primary Study Evaluating the Usefulness of 18F-Sodium Fluoride (NaF) PET-CT.
Usmani S; Marafi F; Ahmed N; Esmail A; Al Kandari F; Van den Wyngaert T
Clin Nucl Med; 2017 Nov; 42(11):829-836. PubMed ID: 28872551
[TBL] [Abstract][Full Text] [Related]
18. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
Minamimoto R; Loening A; Jamali M; Barkhodari A; Mosci C; Jackson T; Obara P; Taviani V; Gambhir SS; Vasanawala S; Iagaru A
J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167
[TBL] [Abstract][Full Text] [Related]
19. Burden of metastatic bone disease measured on 18F-NaF PET/computed tomography studies as a prognostic indicator in patients with medullary thyroid cancer.
Ueda CE; Duarte PS; de Castroneves LA; Flávio J; Marin G; Sado HN; Sapienza MT; Hoff AO; Buchpiguel CA
Nucl Med Commun; 2020 May; 41(5):469-476. PubMed ID: 32187160
[TBL] [Abstract][Full Text] [Related]
20. Observer Agreement and Accuracy of
Zacho HD; Fonager RF; Nielsen JB; Haarmark C; Hendel HW; Johansen MB; Mortensen JC; Petersen LJ
J Nucl Med; 2020 Mar; 61(3):344-349. PubMed ID: 31481577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]